Randomized, double-blind cross-over study of acute cisplatin-induced nausea and vomiting, comparing a new schedule of the combination of metoclopramide and methylprednisolone versus metoclopramide alone
- 1 September 1990
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 1 (5) , 379-380
- https://doi.org/10.1093/oxfordjournals.annonc.a057780
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Antiemetic activity of high doses of metoclopramide combined with methylprednisolone versus metoclopramide alone in cisplatin-treated cancer patients: a randomized double-blind trial of the Italian Oncology Group for Clinical Research.Journal of Clinical Oncology, 1987
- Maintenance of Antiemetic Effect of a Metoclopramide-Dexamethasone Combination during Subsequent Cisplatin CoursesOncology, 1986
- The use of methylprednisolone and metoclopramide in control of emesis in patients receiving cis-platinumGynecologic Oncology, 1985
- High-dose intravenous metoclopramide versus combination high-dose metoclopramide and intravenous dexamethasone in preventing cisplatin-induced nausea and emesis: a single-blind crossover comparison of antiemetic efficacy.Journal of Clinical Oncology, 1985
- Improved control of cisplatin-induced emesis with high-dose metoclopramide and with combinations of metoclopramide, dexamethasone, and diphenhydramine. Results of consecutive trials in 255 patientsCancer, 1985